To purchase Allergan, AbbVie sells $30B worth of bonds — 4 insights

AbbVie made the fourth largest corporate bond sale of all time when it sold $30 billion worth of bonds to partially finance its $83 billion takeover of Allergan, the Financial Times reports.

What you should know:

1. AbbVie split the bond offering across 10 offerings, with maturity rates between 18 months and 30 years.

2. It was the largest bond offering since CVS raised $40 billion to take over Aetna.

3. High demand for the bonds among traders will reduce how much AbbVie has to borrow to fund the rest of its acquisition.

4. AbbVie now has a total debt around $90 billion, making it one of the most indebted companies in the world.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast